My Companies
Notification
Account
Log Out
Back

RPG Life Sciences Board Approves ₹243 Crore Investment And Actis Generics Acquisition

29 July 2026
RPG Life Sciences Ltd.

Board approved slump sale of API business to WOS RPG Active Pharma for Rs 33.55 Cr. RPGAP to receive Rs 243.33 Cr from PE investors for ~40% stake (commitment upto Rs 700 Cr for growth) and acquire Actis Generics for Rs 80 Cr.

Recent Events

29 July 2026

RPG Life Sciences Carves Out API Business, Raises ₹243 Crore From InvAscent
29 July 2026

RPG Life Sciences Approves ₹243 Crore API Subsidiary Investment And Acquisition
29 July 2026

RPG Life Sciences Approves Rs 243 Crore Investment, Actis Generics Acquisition

Real time WhatsApp alerts using AI.

Get features of

  • Instant Notifications
  • Competitive Advantage
  • Critical Alerts
Signup or Sign in

Company Information